SenesTech, Inc.
General ticker "SNES" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $4.4M (TTM average)
SenesTech, Inc. follows the US Stock Market performance with the rate: 43.5%.
Estimated limits based on current volatility of 3.8%: low 2.78$, high 3.00$
Factors to consider:
- Total employees count: 23 as of 2024
- Top business risk factors: Commercialization challenges, Sales infrastructure, Manufacturing scale up, Supply chain disruptions, Product liability
- Price in estimated range
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [1.76$, 5.59$]
- 2025-12-31 to 2026-12-31 estimated range: [1.59$, 4.94$]
Financial Metrics affecting the SNES estimates:
- Positive: with PPE of -0.3 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -277.43 <= 0.33
- Negative: negative Net income
- Positive: Shareholder equity ratio, % of 76.60 > 63.39
- Positive: Industry inventory ratio change (median), % of -0.31 <= -0.15
- Positive: 0 < Industry earnings per price (median), % of 2.23
Short-term SNES quotes
Long-term SNES plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $1.02MM | $1.19MM | $1.86MM |
| Operating Expenses | $10.69MM | $8.93MM | $8.11MM |
| Operating Income | $-9.67MM | $-7.73MM | $-6.25MM |
| Non-Operating Income | $-0.02MM | $0.02MM | $0.07MM |
| Interest Expense | $0.00MM | $0.00MM | $0.02MM |
| R&D Expense | $1.86MM | $1.23MM | $1.71MM |
| Income(Loss) | $-9.70MM | $-7.71MM | $-6.18MM |
| Profit(Loss)* | $-9.70MM | $-7.71MM | $-6.18MM |
| Stockholders Equity | $5.28MM | $6.35MM | $2.51MM |
| Inventory | $0.85MM | $0.80MM | $0.79MM |
| Assets | $6.78MM | $7.29MM | $3.28MM |
| Operating Cash Flow | $-8.58MM | $-7.57MM | $-6.03MM |
| Capital expenditure | $0.17MM | $0.15MM | $0.08MM |
| Investing Cash Flow | $-0.17MM | $-0.15MM | $-0.06MM |
| Financing Cash Flow | $4.20MM | $8.34MM | $2.00MM |
| Earnings Per Share** | $-1,860.49 | $-115.10 | $-8.86 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.